Reduced dementia risk in patients with optimized anticoagulation therapy undergoing atrial fibrillation ablation

Atrial fibrillation (AF) is associated with the development of dementia and observational studies have shown that oral anticoagulation (OAC) and catheter ablation reduce dementia risk. However, such studies did not consistently report on periprocedural anticoagulation and long term OAC coverage, for which reason the separate effect of AF ablation on dementia risk could not be established.

Source: Heart Rhythm - April 9, 2024 Category: Cardiology Authors: Finn Åkerström, Emmanouil Charitakis, Astrid Paul-Nordin, Frieder Braunschweig, Leif Friberg, Fariborz Tabrizi, Mats Jensen-Urstad, Nikola Drca Source Type: research